Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into ...

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

A Phase 2 trial of MTX-463 in idiopathic pulmonary fibrosis expected in 1H 2025.

Israel and its allies have escalated strikes against the Houthis, trying to force the Iran-backed group to stop firing on Israel and Red Sea shipping. By Aaron Boxerman and Ismaeel Naar The ...

U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...

Supreme Court Seems Poised to Uphold Law That Could Ban TikTok The justices are expected to rule quickly in the case, which pits national security concerns about China against free speech ...

The wildfires ravaging Southern California are making no exceptions for fancy neighborhoods like the Pacific ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

New research sheds light on how sleep helps the brain to clean itself, raising concerns about how a widely used sleep aid may interfere with this process. Scientists have long believed that sleep acts ...